M-Eslon (morphine sulfate) ER capsules: One lot recalled as some bottles labelled as M-Eslon 30 mg may contain 60 mg capsules, which may pose an overdose risk
What the notice records
| Product | M-Eslon (morphine sulfate) bottles labelled to contain 30 mg extended-release capsules may contain 60 mg extended-release capsules |
|---|---|
| Issue | Product safety |
| What you should do | Check your M-Eslon (morphine sulfate) medication bottle or package. If your prescription is for 30 mg, the capsules should be pink and clear. If it contains 60 mg capsules (orange and clear), or if you are unsure, do not take these capsules and contact your pharmacy immediately. Your pharmacist will check the capsules and provide you with a replacement if needed. Return the affected product to your pharmacy for proper disposal.Call 911 immediately and seek immediate medical attention if you or someone you are caring for is experiencing an overdose (e.g., slow breathing, drowsiness, or difficulties waking up).If an overdose is suspected, administer naloxone nasal spray or injection without delay. Give a repeat dose after 2 to 3 minutes if the person has not woken up or their breathing has not improved.Contact your health care professional if you have taken the wrong dose of your medication and have any health concerns.If you have questions about this recall contact Ethypharm Inc. by calling 1-855-694-0151, or by emailing [email protected] any health product-related side effectsor complaints to Health Canada.Additional information for health professionals:Health care professionals, such as pharmacists, should check bottles labelled as M-Eslon (morphine sulfate) 30 mg extended release (ER) capsules before dispensing to make sure they do not contain M-Eslon 60 mg ER capsules. Report any unusual bottles or other issues to the company and to Health Canada. |
| Category | Drugs |
| Publishing body | Communications and Public Affairs Branch |
| Class | Class not stated |
| Last updated | 2024-09-27 |
Read the official notice on recalls-rappels.canada.ca
Everything in Drugs · Everything from Communications and Public Affairs Branch
Read this correctly
This page reproduces the fields published on the notice and links to the notice itself. It is not a rating and not a statement about a product's current condition, availability or safety.
This notice carries no class in the published data. A blank class means the field is blank — it is not a statement that the product was low risk.
Privacy
This site publishes records that governments already publish. It sets no cookie and makes no request to Google unless you accept one. Read more below.
About this record
Every recall notice published by Health Canada: the product, the issue recorded against it, the class assigned, and the official notice itself. A record of what was published, on the date it was published.
Source: Health Canada — Recalls and safety alerts (open data) — Open Government Licence – Canada. Data refreshes daily. Every page links the row it came from.
What this site is not. It is a copy of an official record. It is not a judgement about any business, building or person, and it is not advice. If the record is wrong, the source above is where it is corrected.